Genetophysiology: Using genetic strategies to explore hypoxic adaptation

High Altitude Medicine and Biology

Volumn 9, Issue 2, 2008, Pages 123-129

  Grocott, Mike ^a   Montgomery, Hugh ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Adaptation; Genetic polymorphism; Genome; SNP

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA;

ALTITUDE ACCLIMATIZATION; BRAIN EDEMA; GENETIC POLYMORPHISM; GENOME; HUMAN; HYPOXIA; LINKAGE ANALYSIS; MOUNTAINEERING; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ACCLIMATIZATION; ADAPTATION, PHYSIOLOGICAL; ANOXIA; ENVIRONMENTAL EXPOSURE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 46249106731     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2008.1012     Document Type: Review

References (70)

1. Ahsan A., Mohd G., Norboo T., Baig M.A., and Pasha M.A. (2006). Heterozygotes of NOS3 polymorphisms contribute to reduced nitrogen oxides in high-altitude pulmonary edema. Chest. 130(5):1511-1519.
2. Aldashev A.A., Sarybaev A.S., Sydykov A.S., Kalmyrzaev B.B., Kim E.V., Mamanova L.B., Maripov R., Kojonazarov B.K., Mirrakhimov M.M., Wilkins M.R., and Morrell N.W. (2002). Characterization of high-altitude pulmonary hypertension in the Kyrgyz:association with angiotensin-converting enzyme genotype. Am. J. Respir. Crit. Care Med. 166(10):1396-1402.
3. Alvarez R., Terrados N., Ortolano R., Iglesias-Cubero G., Reguero J.R., Batalla A., Cortina A., Fernandez-Garcia B., Rodriguez C., Braga S., Alvarez V., and Coto E. (2000). Genetic variation in the renin-angiotensin system and athletic performance. Eur. J. Appl. Physiol. 82(1-2):117-120.
4. Ameri K., Burke B., Lewis C.E., and Harris A.L. (2002). Regulation of a rat VL30 element in human breast cancer cells in hypoxia and anoxia:role of HIF-1. Br. J. Cancer 87(10):1173-1181.
5. Bogaard, H.J., Hopkins S.R., Yamaya Y., Niizeki K., Ziegler M.G., and Wagner P.D. (2002). Role of the autonomic nervous system in the reduced maximal cardiac output at altitude. J. Appl. Physiol. 93(1):271-279.
6. Cam, F.S., Colakoglu M., Sekuri C., Colakoglu S., Sahan C., and Berdeli A. (2005). Association between the ACE I/D gene polymorphism and physical performance in a homogeneous non-elite cohort. Can. J. Appl. Physiol. 30(1):74-86.
7. Cam S., Colakoglu M., Colakoglu S., Sekuri C., and Berdeli A. (2007). ACE I/D gene polymorphism and aerobic endurance development in response to training in a non-elite female cohort. J. Sports Med. Phys. Fitness 47(2):234-238.
8. Charu R., Stobdan T., Ram R.B., Khan A.P., Qadar Pasha M.A., Norboo T., and Afrin F. (2006). Susceptibility to high altitude pulmonary oedema:role of ACE and ET-1 polymorphisms. Thorax. 61(11):1011-1012.
9. Collins M., Xenophontos S.L., Cariolou M.A., Mokone G.G., Hudson D.E., Anastasiades L., and Noakes T.D. (2004). The ACE gene and endurance performance during the South African Ironman Triathlons. Med. Sci. Sports Exerc. 36(8):1314-1320.
10. Costerousse O., Allegrini J., Lopez M., and Alhenc-Gelas F. (1993). Angiotensin I-converting enzyme in human circulating mononuclear cells:genetic polymorphism of expression in T-lymphocytes. Biochem. J. 290 (Pt 1):33-40.
11. Cymerman A., Reeves J.T., Sutton J.R., Rock P.B., Groves B.M., Malconian M.K., Young P.M., Wagner P.D., and Houston C.S. (1989). Operation Everest II:maximal oxygen uptake at extreme altitude. J. Appl. Physiol. 66(5):2446-2453.
12. Damert A., Ikeda E., and Risau W. (1997). Activator-protein-1 binding potentiates the hypoxia-inducible factor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem. J. 327 (Pt 2):419-423.
13. Danser A.H., Schalekamp M.A., Bax W.A., van den Brink A.M., Saxena P.R., G. Riegger A., and Schunkert H. (1995). Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation. 92(6):1387-1388.
14. Dehnert C., Weymann J., Montgomery H.E., Woods D., Maggiorini M., Scherrer U., Gibbs J.S., and Bartsch P. (2002). No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med. Sci. Sports Exerc. 34(12):1928-1933.
15. Dekany M., Harbula I., Berkes I., Gyore I., Falus A., and Pucsok J. (2006). The role of insertion allele of angiotensin converting enzyme gene in higher endurance efficiency and some aspects of pathophysiological and drug effects. Curr. Med. Chem. 13(18):2119-2126.
16. Dempsey J.A., Thomson J.M., Forster H.V., Cerny F.C., and Chosy L.W. (1975). HbO2 dissociation in man during prolonged work in chronic hypoxia. J. Appl. Physiol. 38(6):1022-1029.
17. di Prampero P.E. (1992). An analysis of the factors limiting maximal oxygen consumption in healthy subjects. Chest. 101(5 Suppl):188S-191S.
18. di Prampero P.E., and Ferretti G. (1990). Factors limiting maximal oxygen consumption in humans. Respir. Physiol. 80(2-3): 113-127.
19. Elvert G., Kappel A., Heidenreich R., Englmeier U., Lanz S., Acker T., Rauter M., Plate K., Sieweke M., Breier G., and Flamme I. (2003). Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J. Biol. Chem. 278(9):7520-7530.
20. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., and Ratcliffe P.J. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107(1):43-54.
21. Gonzalez A.J., Hernandez D., De Vera A., Barrios Y., Salido E., Torres A., and Terrados N. (2006). ACE gene polymorphism and erythropoietin in endurance athletes at moderate altitude. Med. Sci. Sports Exerc. 38(4):688-693.
22. Hanaoka M., Droma Y., Hotta J., Matsuzawa Y., Kobayashi T., Kubo K., and Ota M. (2003). Polymorphisms of the tyrosine hydroxylase gene in subjects susceptible to high-altitude pulmonary edema. Chest. 123(1):54-58.
23. Hotta J., Hanaoka M., Droma Y., Katsuyama Y., Ota M., and Kobayashi T. (2004). Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects. Chest. 126(3):825-830.
24. Hu B., Wright E., Campbell L., and Blanchard K.L. (1997). In vivo analysis of DNA-protein interactions on the human erythropoietin enhancer. Mol. Cell Biol. 17(2):851-856.
25. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., and Kaelin, Jr. W.G. (2001). HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 292(5516): 464-468.
26. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., Maxwell P.H., C. Pugh W., and Ratcliffe P.J. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292(5516):468-472.
27. Jewell U.R., Kvietikova I., Scheid A., Bauer C., Wenger R.H., and Gassmann M. (2001). Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB J. 15(7):1312-1314.
28. Kaelin W.G. (2005). Proline hydroxylation and gene expression. Annu Rev. Biochem. 74:115-128.
29. Kaelin W.G., Jr. (2002). How oxygen makes its presence felt. Genes Dev. 16(12):1441-1445.
30. Koehle M.S., Wang P., Guenette J.A., and Rupert J.L. (2006). No association between variants in the ACE and angiotensin II receptor 1 genes and acute mountain sickness in Nepalese pilgrims to the Janai Purnima Festival at 4380 m. High Alt. Med. Biol, 7(4):281-289.
31. Kumar R., Pasha Q., Khan A.P., and Gupta V. (2004). Renin angiotensin aldosterone system and ACE I/D gene polymorphism in high-altitude pulmonary edema. Aviat. Space Environ. Med 75(11):981-983.
32. Kvietikova I., Wenger R.H., Marti H.H., and Gassmann M. (1995). The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res. 23(22):4542-4550.
33. Kvietikova I., Wenger R.H., Marti H.H., and Gassmann M. (1997). The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive. Kidney Int. 51(2):564-566.
34. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., and Bruick R.K. (2002a). FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxiainducible factor. Genes Dev. 16(12):1466-1471.
35. Lando D., Peet D.J., Whelan D.A., Gorman J.J., and Whitelaw M.L. (2002b). Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. 295(5556):858-661.
36. Lundby C., Calbet J.A., Sander M., van Hall G., Mazzeo R.S., Stray-Gundersen J., Stager J.M., Chapman R.F., Saltin B., and Levine B.D. (2007). Exercise economy does not change after acclimatization to moderate to very high altitude. Scand. J. Med. Sci. Sports 17(3):281-291.
37. Lundby C., Pilegaard H., Andersen J.L., van Hall G., Sander M., and Calbet J.A. (2004). Acclimatization to 4100 m does not change capillary density or mRNA expression of potential angiogenesis regulatory factors in human skeletal muscle. J. Exp. Biol. 207(Pt 22):3865-3871.
38. MacDougall J.D., Green H.J., Sutton J.R., Coates G., Cymerman A., Young P., and Houston C.S. (1991). Operation Everest II:structural adaptations in skeletal muscle in response to extreme simulated altitude. Acta Physiol. Scand. 142(3):421-427.
39. Mahon P.C., Hirota K., and Semenza G.L. (2001). FIH-1:a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15(20):2675-2686.
40. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., and Ratcliffe P.J. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399(6733):271-275.
41. Min J.H., Yang H., Ivan M., Gertler F., Kaelin W.G., Jr. and Pavletich N.P. (2002). Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science. 296 (5574):1886-1889.
42. Montgomery H.E., Marshall R., Hemingway H., Myerson S., Clarkson P., Dollery C., Hayward M., Holliman D.E., Jubb M., World M., Thomas E.L., Brynes A.E., Saeed N., Barnard M., Bell J.D., Prasad K., Rayson M., Talmud P.J., and Humphries S.E. (1998). Human gene for physical performance. Nature. 393(6682):221-222.
43. Mortimer H., Patel S., and Peacock A.J. (2004). The genetic basis of high-altitude pulmonary oedema. Pharmacol Ther 101(2):183-192.
44. Patel S., Woods D.R., Macleod N.J., Brown A., Patel K.R., Montgomery H.E., and Peacock A.J. (2003). Angiotensin-converting enzyme genotype and the ventilatory response to exertional hypoxia. Eur. Respir. J. 22(5):755-760.
45. Paul M., Poyan Mehr A., and Kreutz R. (2006). Physiology of local renin-angiotensin systems. Physiol. Rev. 86(3):747-803.
46. Qadar Pasha M.A., Khan A.P., Kumar R., Grover S.K., Ram R.B., Norboo T., Srivastava K.K., Selvamurthy W., and Brahmachari S.K. (2001). Angiotensin converting enzyme insertion allele in relation to high altitude adaptation. Ann. Hum. Genet. 65(Pt. 6):531-536.
47. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., and Soubrier F. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86(4):1343-1346.
48. Roberts A.C., Butterfield G.E., Cymerman A., Reeves J.T., Wolfel E.E., and G. Brooks A. (1996). Acclimatization to 4,300-m altitude decreases reliance on fat as a substrate. J. Appl. Physiol. 81(4):1762-1771.
49. Rodriguez H., Drouin R., Holmquist G.P., and Akman S.A. (1997). A hot spot for hydrogen peroxide-induced damage in the human hypoxia-inducible factor 1 binding site of the PGK 1 gene. Arch. Biochem. Biophys. 338(2):207-212.
50. Rolfs A., Kvietikova I., Gassmann M., and Wenger R.H. (1997). Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272(32):20055-62.
51. Rupert J.L., Devine D.V., Monsalve M.V., and Hochachka P.W. (1999). Angiotensin-converting enzyme (ACE) alleles in the Quechua, a high altitude South American native population. Ann. Hum. Biol. 26(4):375-380.
52. Sang N., Fang J., Srinivas V., Leshchinsky I., and Caro J. (2002). Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP. Mol. Cell. Biol. 22(9):2984-2992.
53. Schofield C.J., and Ratcliffe P.J. (2004). Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5(5):343-354.
54. Semenza G.L. (2001a). HIF-1 and mechanisms of hypoxia sensing. Curr. Opinion Cell Biol. 13(2):167-171.
55. Semenza G.L. (2001b). HIF-1, O(2), and the 3 PHDs:how animal cells signal hypoxia to the nucleus. Cell. 107(1):1-3.
56. Semenza G.L. (2006). Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp. Physiol. 91(5):803-806.
57. Smith E.M., Baillie J.K., Thompson A.A., Irving J.B., Porteous D., and Webb D.J. (2006). Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitude. High Alt. Med. Biol. 7(3):221-227.
58. Swanson H.I. (2002). DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation. Chem. Biol. Interact. 141(1-2):63-76.
59. Tsianos G., Eleftheriou K.I., Hawe E., Woolrich L., Watt M., Watt I., Peacock A., Montgomery H., and Grant S. (2005). Performance at altitude and angiotensin I-converting enzyme genotype. Eur. J. Appl. Physiol. 93(5-6):630-633.
60. Wagner P.D., Wagner H.E., Groves B.M., Cymerman A., and Houston C.S. (2007). Hemoglobin P(50) during a simulated ascent of Mt. Everest, Operation Everest II. High Alt. Med. Biol. 8(1):32-42.
61. Ward M.P., Milledge J.S., and West J.P. (2000). High Altitude Medicine and Physiology. London, Arnold.
62. Warnecke C., Zaborowska Z., Kurreck J., Erdmann V.A., Frei U., Wiesener M., and Eckardt K.V. (2004). Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference:erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J. 18(12):1462-1464.
63. Wenger R.H. (2002). Cellular adaptation to hypoxia:O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 16(10):1151-1162.
64. Wenger R.H., Kvietikova I., Rolfs A., Camenisch G., and Gassmann M. (1998). Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur. J. Biochem. 253(3): 771-777.
65. Wenger R.H., Stiehl D.P., and Camenisch G. (2005). Integration of oxygen signaling at the consensus HRE. Sci. STKE 2005 (306):re12.
66. Williams A.G., Rayson M.P., Jubb M., World M., Woods D.R., Hayward M., Martin J., Humphries, S.E., and Montgomery H.E. (2000). The ACE gene and muscle performance. Nature. 403(6770):614.
67. Woods D.R., Pollard A.J., Collier D.J., Jamshidi Y., Vassiliou V., Hawe E., Humphries S.E., and Montgomery H.E. (2002). Insertion/ deletion polymorphism of the angiotensin I-converting enzyme gene and arterial oxygen saturation at high altitude. Am. J. Respir. Crit. Care Med. 166(3):362-366.
68. Yu F., White S.B., Zhao Q., and Lee F.S. (2001). HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. U S A 98(17):9630-9635.
69. Zhou F., Wang F., Li F, Yuan J., Zeng H., Wei Q., Tanguay R.M., and Wu W. (2005). Association of hsp70-2 and hsp-hom gene polymorphisms with risk of acute high-altitude illness in a Chinese population. Cell Stress Chaperones 10(4):349-356.
70. Ziel K.A., Grishko V., Campbell C.C., Breit J.F., Wilson G.L. and Gillespie M.N. (2005). Oxidants in signal transduction:impact on DNA integrity and gene expression. FASEB J. 19(3):387-394.